The inventive method comprises expression of a serin acetyl transferase gene coding for an enzymatically inactive serin acetyl transferase

A Methionine Nα-acetyltransferase enzyme has been identified in yeast.

Novel genetic variants of the Arylalkylamine N-Acetyltransferase (AANAT) gene are described.

The spermidine/spermine N -acetyltransferase substrate may be a monoamine.

The present disclosure is in relation to a composition comprising nanosphere and histone acetyltransferase (HAT) activator.

The present inventors have discovered that serine acetyltransferase (SAT) is essential for plant growth.

The spermidine/spermine N -acetyltransferase substrate may be a monoamine.

Optionally, the acyltransferase-expressing Acremonium strain further does not express hydroxylase and/or acetyltransferase activity.

The methods may be used for determining both acetyltransferase activity and deacetylase activity.

In addition, a variant sequence of one of these enzymes, acetyl-coA acetyltransferase, has been found.

The compositions comprise oligonucleotides, targeted to nucleic acid encoding acetyl-CoA acetyltransferase 2.

This invention is further directed to a method for purifying the Nα-acetyltransferase.

ABSTRACT OF THE DISCLOSURE An anti-cancer drug compound comprises an spermidine/spermine N -acetyltransferase substrate.

The existence of the enzyme defines a gene for methionine Nα-acetyltransferase which may be cloned and altered.

A mutation defining a gene for the Nα-acetyltransferase of yeast has been identified and cloned.